NeuroFlow helps risk-bearing healthcare organizations improve outcomes and cost of care in complex populations by surfacing and supporting behavioral health needs that typically go undetected and under-addressed. Across payors, providers, and the federal government, NeuroFlow’s scalable technology and analytics capabilities empower organizations with actionable intelligence from real-time data collection and risk stratification, enabling them to manage populations in a financially sustainable way. Powered by deep expertise in whole-person care, NeuroFlow offers a path to risk predictability and proactive care that helps overcome the systemic challenges in today’s healthcare ecosystem.
MindSpace is a company that operates in the Biotechnology industry. It employs 1-5 people and has $0M-$1M of revenue. The company is headquartered in the United States.
CognitiveCare is a trailblazing force in improving healthcare outcomes. We utilize scientific rigor to unveil and address health disparities, enhance disease prevention and management, accelerate health economics outcomes research, and catalyze optimal efficacy in pharma and life sciences. With a foundation rooted in patented and proprietary risk quantification and resource allocation algorithms, we serve payers, providers, policymakers, public health departments, pharma, and life sciences clients, driving impact for both individual and population health. CongitiveCare is poised to revolutionize the healthcare landscape through its algorithm hub, interdisciplinary approach, and real-world evidence expertise. The company's impactful strides in maternal and infant health, children's health, mental health, substance use disorder, eye health, infectious diseases, and pathology lay the foundation for accelerating our mission to build healthier communities.